Article Search
검색
검색 팝업 닫기

Metrics

Help

  • 1. Aims and Scope

    Gut and Liver is an international journal of gastroenterology, focusing on the gastrointestinal tract, liver, biliary tree, pancreas, motility, and neurogastroenterology. Gut atnd Liver delivers up-to-date, authoritative papers on both clinical and research-based topics in gastroenterology. The Journal publishes original articles, case reports, brief communications, letters to the editor and invited review articles in the field of gastroenterology. The Journal is operated by internationally renowned editorial boards and designed to provide a global opportunity to promote academic developments in the field of gastroenterology and hepatology. +MORE

  • 2. Editorial Board

    Editor-in-Chief + MORE

    Editor-in-Chief
    Yong Chan Lee Professor of Medicine
    Director, Gastrointestinal Research Laboratory
    Veterans Affairs Medical Center, Univ. California San Francisco
    San Francisco, USA

    Deputy Editor

    Deputy Editor
    Jong Pil Im Seoul National University College of Medicine, Seoul, Korea
    Robert S. Bresalier University of Texas M. D. Anderson Cancer Center, Houston, USA
    Steven H. Itzkowitz Mount Sinai Medical Center, NY, USA
  • 3. Editorial Office
  • 4. Articles
  • 5. Instructions for Authors
  • 6. File Download (PDF version)
  • 7. Ethical Standards
  • 8. Peer Review

    All papers submitted to Gut and Liver are reviewed by the editorial team before being sent out for an external peer review to rule out papers that have low priority, insufficient originality, scientific flaws, or the absence of a message of importance to the readers of the Journal. A decision about these papers will usually be made within two or three weeks.
    The remaining articles are usually sent to two reviewers. It would be very helpful if you could suggest a selection of reviewers and include their contact details. We may not always use the reviewers you recommend, but suggesting reviewers will make our reviewer database much richer; in the end, everyone will benefit. We reserve the right to return manuscripts in which no reviewers are suggested.

    The final responsibility for the decision to accept or reject lies with the editors. In many cases, papers may be rejected despite favorable reviews because of editorial policy or a lack of space. The editor retains the right to determine publication priorities, the style of the paper, and to request, if necessary, that the material submitted be shortened for publication.

Search

Search

Year

to

Article Type

Corrigendum

Split Viewer

Corrigendum to: Is Neoadjuvant Therapy Needed in Patients with Resectable Pancreatic Cancer?

Dong Uk Kim

Department of Internal Medicine, Pusan National University College of Medicine and Biomedical Research Institute, Pusan National University Hospital, Busan, Korea

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Gut Liver 2023;17(2):343-343. https://doi.org/10.5009/gnl210585.e

Published online March 15, 2023, Published date March 15, 2023

Copyright © Gut and Liver.

https://doi.org/10.5009/gnl210585

Gut Liver 2022;16(1):3-4.

In the article entitled “Is Neoadjuvant Therapy Needed in Patients with Resectable Pancreatic Cancer?,”1 the affiliation of the author was incorrectly presented: “Institute, Pusan National University Hospital” should read “Biomedical Research Institute, Pusan National University Hospital.”

  1. Kim DU. Is neoadjuvant therapy needed in patients with resectable pancreatic cancer? Gut Liver 2022;16:3-4.
    Pubmed KoreaMed CrossRef

Article

Corrigendum

Gut and Liver 2023; 17(2): 343-343

Published online March 15, 2023 https://doi.org/10.5009/gnl210585.e

Copyright © Gut and Liver.

Corrigendum to: Is Neoadjuvant Therapy Needed in Patients with Resectable Pancreatic Cancer?

Dong Uk Kim

Department of Internal Medicine, Pusan National University College of Medicine and Biomedical Research Institute, Pusan National University Hospital, Busan, Korea

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Body

https://doi.org/10.5009/gnl210585

Gut Liver 2022;16(1):3-4.

In the article entitled “Is Neoadjuvant Therapy Needed in Patients with Resectable Pancreatic Cancer?,”1 the affiliation of the author was incorrectly presented: “Institute, Pusan National University Hospital” should read “Biomedical Research Institute, Pusan National University Hospital.”

References

  1. Kim DU. Is neoadjuvant therapy needed in patients with resectable pancreatic cancer? Gut Liver 2022;16:3-4.
    Pubmed KoreaMed CrossRef
Gut and Liver

Vol.17 No.6
November, 2023

pISSN 1976-2283
eISSN 2005-1212

qrcode
qrcode

Share this article on :

  • line

Popular Keywords

Gut and LiverQR code Download
qr-code

Editorial Office